AQTIVIDE Trademark

Trademark Overview

On Monday, May 7, 2018, a trademark application was filed for AQTIVIDE with the United States Patent and Trademark Office. The USPTO has given the AQTIVIDE trademark a serial number of 87910222. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 3, 2022. This trademark is owned by Sarepta Therapeutics, Inc.. The AQTIVIDE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders
aqtivide

General Information

Serial Number87910222
Word MarkAQTIVIDE
Filing DateMonday, May 7, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 3, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 2, 2018

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of neuromuscular diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, May 16, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSarepta Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142
Party NameSarepta Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events

Event DateEvent Description
Monday, January 3, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, January 3, 2022ABANDONMENT - NO USE STATEMENT FILED
Friday, May 7, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 6, 2021EXTENSION 5 GRANTED
Monday, April 26, 2021EXTENSION 5 FILED
Thursday, May 6, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, April 26, 2021TEAS EXTENSION RECEIVED
Tuesday, October 27, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 23, 2020EXTENSION 4 GRANTED
Friday, October 23, 2020EXTENSION 4 FILED
Friday, October 23, 2020TEAS EXTENSION RECEIVED
Saturday, March 7, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 5, 2020EXTENSION 3 GRANTED
Thursday, March 5, 2020EXTENSION 3 FILED
Thursday, March 5, 2020TEAS EXTENSION RECEIVED
Thursday, November 21, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 19, 2019EXTENSION 2 GRANTED
Tuesday, November 19, 2019EXTENSION 2 FILED
Tuesday, November 19, 2019TEAS EXTENSION RECEIVED
Saturday, May 18, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 16, 2019EXTENSION 1 GRANTED
Thursday, May 16, 2019EXTENSION 1 FILED
Thursday, May 16, 2019TEAS EXTENSION RECEIVED
Tuesday, November 27, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 2, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 2, 2018PUBLISHED FOR OPPOSITION
Wednesday, September 12, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 28, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 28, 2018ASSIGNED TO EXAMINER
Wednesday, May 16, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, May 10, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

aqtivide diseases disorders neuromuscular treatment preparations pharmaceutical